Tevogen Bio

Performance

About Tevogen Bio

Tevogen Bio is a late-stage biotechnology company specializing in immunotherapy using cytotoxic T lymphocytes. Its ExacTcell platform enables scalable, off-the-shelf allogeneic CTLs for the treatment of cancers, viral infections, and prevention of long-term complications, with applications spanning oncology, neurology, and virology. The company focuses on making personalized T cell therapeutics more affordable and accessible, and is headquartered in New Jersey, United States. Tevogen also explores AI-assisted approaches through Tevogen.AI to accelerate product development while aligning pricing with broad patient access.